RESUMEN
Management and conservation actions in marine-protected areas require baselines for monitoring threatened marine fauna such as elasmobranchs. This article provides evidence of the occurrence of 34 species of elasmobranchs (21 sharks and 13 batoids) in the Malpelo Flora and Fauna Sanctuary, Colombia, including five new records of sharks and three of rays. From 1987 to 2021, new records were obtained by underwater visual census using SCUBA, manned submersibles and deep-ocean cameras to depths of up to 2211 m. Of the recorded species, 21 are considered as threatened taxa (64%) by the IUCN, making the Malpelo Flora and Fauna Sanctuary an essential conservation area for this highly threatened group of species.
Asunto(s)
Ecosistema , Tiburones , Animales , Colombia , Conservación de los Recursos NaturalesRESUMEN
Hadal ecosystems are found at a depth of 6,000 m below sea level and below, occupying less than 1% of the total area of the ocean. The microbial communities and metabolic potential in these ecosystems are largely uncharacterized. Here, we present four single amplified genomes (SAGs) obtained from 8,219 m below the sea surface within the hadal ecosystem of the Puerto Rico Trench (PRT). These SAGs are derived from members of deep-sea clades, including the Thaumarchaeota and SAR11 clade, and two are related to previously isolated piezophilic (high-pressure-adapted) microorganisms. In order to identify genes that might play a role in adaptation to deep-sea environments, comparative analyses were performed with genomes from closely related shallow-water microbes. The archaeal SAG possesses genes associated with mixotrophy, including lipoylation and the glycine cleavage pathway. The SAR11 SAG encodes glycolytic enzymes previously reported to be missing from this abundant and cosmopolitan group. The other SAGs, which are related to piezophilic isolates, possess genes that may supplement energy demands through the oxidation of hydrogen or the reduction of nitrous oxide. We found evidence for potential trench-specific gene distributions, as several SAG genes were observed only in a PRT metagenome and not in shallower deep-sea metagenomes. These results illustrate new ecotype features that might perform important roles in the adaptation of microorganisms to life in hadal environments.
Asunto(s)
Archaea/clasificación , Archaea/genética , Genoma Arqueal/genética , Metagenoma/genética , Agua de Mar/microbiología , Aclimatación , Archaea/aislamiento & purificación , Secuencia de Bases , ADN de Archaea/genética , Ecosistema , Metabolismo Energético/fisiología , Ácidos Grasos/metabolismo , Lípidos/biosíntesis , Datos de Secuencia Molecular , Océanos y Mares , Puerto Rico , ARN Ribosómico 16S/genética , Análisis de Secuencia de ADN , Azufre/metabolismo , Microbiología del AguaRESUMEN
Intradermal vaccines consisting of viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, or mixtures of the two were titrated in mice in doses of 10(5.2), 10(5.8), 10(6.4), 10(7.0), and 10(7.6) acid-fast bacilli. The immune response was measured by sensitization (48 to 72 h foot pad enlargement on challenge with 10(7.0) heat-killed M. leprae) and by protection against infection with a viable M. leprae challenge. There was increasing response with increasing dose of vaccine, and overall the responses to the three vaccines were similar. At the lowest dose, however, the combination of BCG and M. leprae gave superior protection. The local reaction to the vaccines in the lower dose range was less severe with the M. leprae vaccine. In another experiment, the three vaccines were compared in normal mice and in mice that had been rendered tolerant by intravenous injection of M. leprae. The tolerant mice developed no measurable sensitization on vaccination with M. leprae, but they developed partial but distinct sensitization on vaccination with BCG, alone or in combination with M. leprae. The tolerant mice developed little or no protection with any of the vaccines, however..
Asunto(s)
Femenino , Animales , Ratones , Lepra/inmunología , Mycobacterium leprae/inmunología , Relación Dosis-Respuesta Inmunológica , Tolerancia Inmunológica , Vacuna BCG/inmunología , Vacunas Bacterianas/inmunología , VacunaciónAsunto(s)
Humanos , Lepra/clasificación , Lepra/complicaciones , Lepra/diagnóstico , Lepra/prevención & control , Lepra/terapia , Mycobacterium leprae/inmunología , Mycobacterium leprae/patogenicidad , Clofazimina/administración & dosificación , Clofazimina/uso terapéutico , Dapsona/administración & dosificación , Dapsona/uso terapéutico , Rifampin/administración & dosificación , Rifampin/uso terapéuticoRESUMEN
All mycobacteria species share some antigens, so there may be cultivable mycobacterial cultures that can provide vaccine protection against leprosy. Vaccine protection against Mycobacterium leprae infections in mice has been demonstrated for M. leprae itself, as living or heat-killed suspensions, and for Mycobacterium bovis (BCG), as living suspensions. Results are reported here with 17 other cultures. The mycobacterial suspensions were injected intradermally, and the mice were challenged in the footpad with infectious suspensions of M. leprae. In two experiments the mice were also challenged by footpad injections of 10(7) heat-killed M. leprae so the footpad enlargment could be measured. That some mycobacterial suspensions were immunogenic for some of their own antigens was suggested by reactions at the vaccine site and enlargement of the regional lymph nodes. Some mycobacterial suspensions also stimulated footpad enlargement on challenge by homologous suspensions or by challenge with M. leprae suspensions. Consistent protection against infectious challenge with M. leprae was observed only with BCG and M. leprae, however...
Asunto(s)
Femenino , Animales , Ratones , Lepra/prevención & control , Ganglios Linfáticos/inmunología , Mycobacterium bovis/inmunología , Mycobacterium leprae/inmunología , Mycobacterium/inmunología , Vacuna BCG/uso terapéutico , Vacunas Bacterianas/uso terapéuticoRESUMEN
The protection provided to mice by vaccines administered intradermally was measured after footpad challenge with Mycobacterium leprae. The protection offered by M. leprae suspensions was not decreased when the vaccines were killed by 60 degrees C heat or at the higher temperatures tested, which included 215 degrees C (autoclave). Even highly purified suspensions retained their immunogenicity. In contrast, the vaccine protection provided by intradermal M. bovis (strain BCG) was markedly reduced when heated to 60 degrees C. The enlargement of the lymph nodes regional to the intradermal vaccines was measured and found generally to parallel the vaccine protection provided by M. leprae and by BCG.
Asunto(s)
Animales , Ratones , Lepra/inmunología , Inmunidad Celular , Inyecciones Intradérmicas , Inyecciones Subcutáneas , Mycobacterium bovis , Mycobacterium leprae/inmunología , Vacuna BCG , Vacunas Bacterianas/administración & dosificación , Vacunas Bacterianas/inmunología , Vacunas Bacterianas/normas , Congelación , CalorRESUMEN
Mycobacterial ribonucleic acid preparations from H37Ra, an attenuated strain of Mycobacterium tuberculosis, provide their usual marked protection against M. tuberculosis challenge; however, they provided no protection against Mycobacterium leprae challenge. Suspensions of intact H37Ra were not effective against M. leprae. Suspensions of BCG gave their usual distinct protection against M. leprae challenge.
Asunto(s)
Animales , Ratones , Lepra/inmunología , Lepra/prevención & control , Mycobacterium tuberculosis/inmunología , ARN Bacteriano/farmacología , Reacciones Cruzadas , Vacuna BCGRESUMEN
The immunological status of leprosy patients is reflected in the clinical picture. Figure 1 and 2 illustrate the lepromatous variety.
Asunto(s)
Masculino , Humanos , Animales , Adulto , Persona de Mediana Edad , Ratones , Lepromina/administración & dosificación , Lepra/clasificación , Lepra/inmunología , Lepra/patología , Mycobacterium leprae/inmunología , Piel/inmunología , Piel/patología , Pruebas Cutáneas , Vacuna BCGRESUMEN
Rifampin was rapidly bactericial for Mycobacterium leprae. Leprosy responds very slowly to current therapy, so there is a special need for more rapidly effective drugs. In mice rifampin exerted a bactericidal-type effect with single administration by gavage; the effect increased with dosage in the range 10 to 40 mg/kg of body weight. Five patients with lepromatous disease were treated with 600 mg rifampin daily, and the viability of the bacilli in their skin lesions was tested by inoculation of mice. Infectivity for mice had completely disappeared in the 1st specimen collected after the start of therapy - at 7 days in 4 patients and 14 days in 1. In 4 control patients treated with dapsone, infectivity for mice was lost much more slowly and in 1 was still present, though decreased, 112 days after the start of treatment. The slower loss of infectivity with dapsone is in accord with our previous experience in which the same methods were used.
Asunto(s)
Humanos , Animales , Ratones , Biopsia , Dapsona/uso terapéutico , Lepra/tratamiento farmacológico , Mycobacterium leprae , Piel/microbiología , Rifampin/uso terapéuticoRESUMEN
A series of drugs that had been found active against Mycobacterium leprae in mice by the continous method of drug administration was tested by the kinetic method. Vadrine and vyomivin were found inactive. Cephaloridine, streptovaricin, and rifampin gave bactericidal-type results. In a second experiment, rifampin was found to have distinct bactericidal effect when given for only 2 days. The plasma levels of rifampin that were associated with bactericidal effect in mice were in the range reported for man receiving acceptable dosages of rifampin. Cephaloridine and, especially, rifampin merit further investigation in clinical trials in leprosy patients, either as single drugs or in combination with other active drugs. The combination of rifampin and dapsone (DDS) or acedapsone (DADDS) appear to provide the advantages of tboth drugs.